What is it? Why is it important?

During study conduct, the study monitor checks among others the quality and integrity of the study data.

 

With respect to Data Managment (DM) responsibilities, the monitor:

  • Checks whether data entry is correct and recorded in a timely manner
    • Recorded entries in the database correspond to SD (original data)
    • Data entries are done in close proximity to participant visits
  • Creates queries in the event of data inconsistencies or errors
  • Supervises query resolution by study site  (e.g. query management, and pending issues)
  • Reports any inconsistencies to the SP-INV in order to define applicable corrective and preventive actions
  • Checks upon subsequent monitoring visits the implementation of any outstanding actions

 

Monitoring  requirements are based on study type (ClinO, ClinO-MD, HRO) and the risk-category of the study (A low risk, B or C high risk).

What do I need to do?

As a SP-INV, based on your study design and the risk-category of your study:

  • Assess the monitoring requirements of your study and how it affects DM aspects
  • Establish a requirement profile for a study monitor

 

As a SP-INV define the:

  • Frequency and type of monitoring (e.g. one or several spaced monitoring visits, on-site or central monitoring)
  • Extent of monitoring (e.g. what data to check) and the scope of data to monitor (e.g. all collected data, only a given data percentage)

 

Planned study monitoring activities are summarised in the Monitoring Plan (MP) of the study. It describes the monitoring strategy by defining scope, frequency and type of monitoring. 

The MP must be submitted for approval to the Ethics Committee (EC) prior to study start. This includes any subsequent changes or adaptations thereof.

Where can I get help?

Your local CTU can support you with experienced staff regarding this topic

References

ICH GCP E6(R2) – see in particular guidelines

  • Art. 1.38 Monitoring
  • Art. 5.5 Trial Management, data handling, and record-keeping
  • Art. 5.18 Monitoring activities

Swiss Law

ClinO – see in particular article

  • Art. 5 Rules of Good Clinical Practice.

Documents

Abbreviations
  • ClinO – Clinical Trials Ordinance
  • ClinO-MD – Ordinance on Clinical Trials with Medical Devices
  • CTU – Clinical Trials Unit
  • DM – Data Management
  • EC – Ethics Committee
  • HRO – Human Research Ordinance
  • MP – Monitoring Plan
  • SD – Source Data
  • SP-INV – Sponsor-Investigator
Concept ↦ Data Management ↦ Stakeholders ↦ Monitor
Study
Basic

Provides some background knowledge and basic definitions

Basic Monitoring
Basic Drug or Device
Concept

Starts with a study idea

Ends after having assessed and evaluated study feasibility

Concept Statistic Methodology
Concept Drug or Device
Development

Starts with confidence that the study is feasible

Ends after having received ethics and regulatory approval

Development Drug or Device
Set-Up

Starts with ethics and regulatory approval

Ends after successful study initiation

Set-Up Ethics and Laws
Set-Up Statistic Methodology
Set-Up Quality and Risk
Set-Up Drug or Device
Conduct

Starts with participant recruitment

Ends after the last participant has completed the last study visit

Conduct Statistic Methodology
Conduct Drug or Device
Completion

Starts with last study visit completed

Ends after study publication and archiving

Completion Statistic Methodology
Completion Drug or Device
Current Path (click to copy): Concept ↦ Data Management ↦ Stakeholders ↦ Monitor

Please note: the Easy-GCS tool is currently under construction.